(Q41522249)

2 October 2017

title

Viral hemagglutinin augments peptide-specific cytotoxic T cell responses (English)

1 reference

2 October 2017

Ertel C

1

1 reference

2 October 2017

Millar NS

2

1 reference

2 October 2017

Emmerson PT

3

1 reference

2 October 2017

Schirrmacher V

4

1 reference

2 October 2017

von Hoegen P

5

1 reference

2 October 2017

language of work or name

English

0 references

publication date

1 October 1993

1 reference

European Journal of Immunology

2 October 2017

published in

1 reference

2 October 2017

volume

23

1 reference

2 October 2017

issue

10

1 reference

2 October 2017

page(s)

2592-2596

1 reference

A method for rapid screening of recombinant proteins for recognition by T lymphocytes

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

T-cell immunity to the joining region of p210BCR-ABL protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Modification of tumor cells by a low dose of Newcastle disease virus. Augmentation of the tumor-specific T cell response in the absence of an anti-viral response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Molecular cloning of complementary DNA to Newcastle disease virus, and nucleotide sequence analysis of the junction between the genes encoding the haemagglutinin-neuraminidase and the large protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Nucleotide sequence analysis of the haemagglutinin-neuraminidase gene of Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Location of a neutralizing epitope for the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Virus-augmented tumor transplantation antigens: evidence for a Helper antigen mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Avian cells expressing the Newcastle disease virus hemagglutinin-neuraminidase protein are resistant to Newcastle disease virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Gangliosides as paramyxovirus receptor. Structural requirement of sialo-oligosaccharides in receptors for hemagglutinating virus of Japan (Sendai virus) and Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830231032

7 January 2021

Identifiers

DOI

10.1002/EJI.1830231032

1 reference

2 October 2017

1 reference